Cargando…

What is the optimal cut-off threshold in self-home blood pressure measurement?: A cohort study according to STROBE statement

Two aspects arise concerning the use of self-measured blood pressure monitoring to diagnose white-coat hypertension (WCH): the presence of target organ damage (TOD) and the normal cut-off threshold. This study aims to evaluate the cardiovascular risk of WCH according to different self-measured blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coll-de-Tuero, Gabriel, Saez, Marc, Rodriguez-Poncelas, Antonio, Bayó-Llibre, Joan, Beltran-Vilella, Marta, Reyes-Negre, Carla, Dalfó-Baqué, Antoni, Barceló, MªAntonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417491/ https://www.ncbi.nlm.nih.gov/pubmed/30855506 http://dx.doi.org/10.1097/MD.0000000000014817

Ejemplares similares

Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort
por: Rodríguez-Poncelas, Antonio, et al.
Publicado: (2018)

The dynamic behaviour of metabolic syndrome and its components in an eight-year population-based cohort from the Mediterranean
por: Barceló, Maria A., et al.
Publicado: (2017)

Effects of the Financial Crisis on Psychotropic Drug Consumption in a Cohort from a Semi-Urban Region in Catalonia, Spain
por: Barceló, Maria A., et al.
Publicado: (2016)

Treatment efficacy of anti-hypertensive drugs in monotherapy or combination: ATOM systematic review and meta-analysis of randomized clinical trials according to PRISMA statement
por: Paz, Marco A., et al.
Publicado: (2016)

STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies
por: Bharucha, Tehmina, et al.
Publicado: (2020)

Practical application of the ATOM study: Treatment efficacy of antihypertensive drugs in monotherapy or combination (ATOM metaanalysis according to PRISMA statement); tables for the use of antihypertensive drugs in monotherapy or combination
por: Paz, Marco A., et al.
Publicado: (2019)

Uses and misuses of the STROBE statement: bibliographic study
por: da Costa, Bruno R, et al.
Publicado: (2011)

CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement
por: Horby, Peter W., et al.
Publicado: (2016)

STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement
por: Gallo, Valentina, et al.
Publicado: (2011)

Strengthening the Reporting of Observational Studies in Epidemiology—Nutritional Epidemiology (STROBE-nut): An Extension of the STROBE Statement
por: Lachat, Carl, et al.
Publicado: (2016)

Strengthening the Reporting of Observational Studies in Epidemiology – nutritional epidemiology (STROBE‐nut): An extension of the STROBE statement
por: Lachat, C., et al.
Publicado: (2016)

Perspective: An Extension of the STROBE Statement for Observational Studies in Nutritional Epidemiology (STROBE-nut): Explanation and Elaboration
por: Hörnell, Agneta, et al.
Publicado: (2017)

Weaknesses in the reporting of cross-sectional studies according to the STROBE statement: the case of metabolic syndrome in adults from Peru
por: Tapia, Jose Carlos, et al.
Publicado: (2015)

Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area
por: Coll-de-Tuero, Gabriel, et al.
Publicado: (2012)

STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement
por: Little, Julian, et al.
Publicado: (2009)

Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement
por: Little, Julian, et al.
Publicado: (2009)

STrengthening the REporting of Genetic Association studies (STREGA) – an extension of the STROBE statement
por: Little, Julian, et al.
Publicado: (2009)

Evaluation of the Quality of Reporting of Observational Studies in Otorhinolaryngology - Based on the STROBE Statement
por: Hendriksma, Martine, et al.
Publicado: (2017)

HMMER Cut-off Threshold Tool (HMMERCTTER): Supervised classification of superfamily protein sequences with a reliable cut-off threshold
por: Pagnuco, Inti Anabela, et al.
Publicado: (2018)

Comparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk
por: Rodriguez-Poncelas, Antonio, et al.
Publicado: (2015)

Reporting guidelines for health care simulation research: extensions to the CONSORT and STROBE statements
por: Cheng, Adam, et al.
Publicado: (2016)

Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex
por: Vanaclocha-Espi, Mercedes, et al.
Publicado: (2021)

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
por: von Elm, Erik, et al.
Publicado: (2007)

Impact of chronic kidney disease on the prevalence of cardiovascular disease in patients with type 2 diabetes in Spain: PERCEDIME2 study
por: Rodriguez-Poncelas, Antonio, et al.
Publicado: (2014)

Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement
por: Poorolajal, Jalal, et al.
Publicado: (2011)

Addressing the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement in Archives of Plastic Surgery Reports
por: Lee, Jang Hyun
Publicado: (2014)

Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement
por: White, Richard G., et al.
Publicado: (2015)

Methods and Processes of Developing the Strengthening the Reporting of Observational Studies in Epidemiology – Veterinary (STROBE‐Vet) Statement
por: Sargeant, J.M., et al.
Publicado: (2016)

Using the STROBE statement to assess reporting in blindness prevalence surveys in low and middle income countries
por: Ramke, Jacqueline, et al.
Publicado: (2017)

Explanation and Elaboration Document for the STROBE‐Vet Statement: Strengthening the Reporting of Observational Studies in Epidemiology—Veterinary Extension
por: O'Connor, A.M., et al.
Publicado: (2016)

Endorsing the STrengthening the Reporting of Observational Studies in Epidemiology-nutritional epidemiology (STROBE-nut) statement at Genes & Nutrition
por: Hawwash, Dana, et al.
Publicado: (2019)

Do CRISPR Germline Ethics Statements Cut It?
por: Brokowski, Carolyn
Publicado: (2018)

Changes in cognitive characteristics according to 3 intensity changes by 8 vibration frequencies (STROBE)
por: Choi, Mi-Hyun, et al.
Publicado: (2021)

Threshold of Nuchal Translucency for the Detection of Chromosomal Aberration: Comparison of Different Cut-offs
por: Kim, Min-Hyoung, et al.
Publicado: (2006)

Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study
por: Rodriguez-Poncelas, Antonio, et al.
Publicado: (2013)

Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes
por: Rodríguez-Poncelas, Antonio, et al.
Publicado: (2016)

International Olympic Committee Consensus Statement: Methods for Recording and Reporting of Epidemiological Data on Injury and Illness in Sports 2020 (Including the STROBE Extension for Sports Injury and Illness Surveillance (STROBE-SIIS))
por: Bahr, Roald, et al.
Publicado: (2020)

International Olympic Committee consensus statement: methods for recording and reporting of epidemiological data on injury and illness in sport 2020 (including STROBE Extension for Sport Injury and Illness Surveillance (STROBE-SIIS))
por: Bahr, Roald, et al.
Publicado: (2020)

The STROBE guidelines
por: Cuschieri, Sarah
Publicado: (2019)

Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
por: Ruiz-Tamayo, Irene, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t81fbjm8uq4se1jvfbife7dv6t